ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 723,90
0,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioNTech SE (BNTX)

  7. BioNTech SE (BNTX) Actualités

BNTX

BioNTech (BNTX)

BioNTech SE
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BNTX
DateHeureSourceTitreSymboleSociété
01/06/202416h00GlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
29/05/202414h00GlobeNewswire Inc.BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine EcosystemNASDAQ:BNTXBioNTech SE
27/05/202402h00PR Newswire (US)MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnershipNASDAQ:BNTXBioNTech SE
21/05/202422h36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
21/05/202412h45GlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024NASDAQ:BNTXBioNTech SE
17/05/202417h15GlobeNewswire Inc.BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024NASDAQ:BNTXBioNTech SE
06/05/202414h09IH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:BNTXBioNTech SE
06/05/202412h45GlobeNewswire Inc.BioNTech Announces First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
26/04/202413h48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNASDAQ:BNTXBioNTech SE
24/04/202413h28IH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNASDAQ:BNTXBioNTech SE
22/04/202412h45GlobeNewswire Inc.BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024NASDAQ:BNTXBioNTech SE
07/04/202420h00GlobeNewswire Inc.Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic CancerNASDAQ:BNTXBioNTech SE
21/03/202412h17IH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNASDAQ:BNTXBioNTech SE
20/03/202412h17IH Market NewsU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices DipNASDAQ:BNTXBioNTech SE
20/03/202411h15GlobeNewswire Inc.BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
20/03/202411h00GlobeNewswire Inc.BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial OfficerNASDAQ:BNTXBioNTech SE
11/03/202412h45GlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024NASDAQ:BNTXBioNTech SE
11/03/202411h25PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTXNASDAQ:BNTXBioNTech SE
07/03/202412h45GlobeNewswire Inc.BioNTech Announces Planned Retirement of Sean MarettNASDAQ:BNTXBioNTech SE
06/03/202412h45GlobeNewswire Inc.BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024NASDAQ:BNTXBioNTech SE
05/03/202411h45PR Newswire (US)The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTXNASDAQ:BNTXBioNTech SE
29/02/202400h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
26/02/202411h45PR Newswire (US)Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BNTXBioNTech SE
22/02/202411h45PR Newswire (US)BioNTech SE Sued for Securities Law Violations - Contact The Gross Law Firm Before March 12, 2024 to Discuss Your Rights - BNTXNASDAQ:BNTXBioNTech SE
15/02/202422h10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BNTXBioNTech SE
14/02/202413h26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BNTXBioNTech SE
09/02/202411h45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) ShareholdersNASDAQ:BNTXBioNTech SE
08/02/202411h45GlobeNewswire Inc.BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs  NASDAQ:BNTXBioNTech SE
08/02/202411h45GlobeNewswire Inc.BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs NASDAQ:BNTXBioNTech SE
02/02/202411h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioNTech SE of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2024 - (NASDAQ: BNTX)NASDAQ:BNTXBioNTech SE
 Showing the most relevant articles for your search:NASDAQ:BNTX

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
AI
Air Liquide
EU
PX1
CAC 40
EU
MC
Lvmh Moet Hennessy Louis...
EU
VIV
Vivendi
EU
LR
Legrand
EU
DG
Vinci
EU
VK
Vallourec
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
EU
RNO
Renault
NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés